/Companies

Keyron Medical

Founded 2016 · 8 employees on LinkedIn · 2 known investors

Find your way into Keyron Medical

Sign up to see every warm intro you have to Keyron Medical

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Keyron Medical team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Keyron develops ForePass, a fully endoscopic, non-invasive and reversible gastric bypass medical device intended to reproduce the effects of metabolic surgery for patients with Class II & III obesity, type 2 diabetes, MASH/NASH, and liver fibrosis. The company targets severe "diabesity" patients who refuse surgery or do not achieve results with drugs, across the US and EU5 markets.

Founders & leadership

Keyron Medical was founded in 2016 by Giorgio Castagneto Gissey.

GCGiorgio Castagneto Gissey
Giorgio Castagneto GisseyChief Executive, Chairman & Co-FounderDr Giorgio Castagneto Gissey is CEO and co-founder of Keyron, which develops an endoscopic gastric bypass device. He previously founded Metadeq, which developed a diagnostic for liver fibrosis, and GHP Scientific and Jemyll; he also held research and teaching positions at Imperial College and UCL, and holds a Ph.D. in Financial Economics from Imperial College Business School and an M.Sc. in Economics from the University of Warwick.
JPJoyce Peetermans
Joyce PeetermansActing CTO
DFDavid Feigal
David FeigalHead of Regulatory Affairs & Board Member
FRFrancesco Rubino
Francesco RubinoChief Officer for Obesity and Diabetes & Board Member
CLCarel le Roux
Carel le RouxChief Medical Officer & Director of Pharmaceutical Division
NV
Nicol VerheemChief Investment Officer, Director of Diagnostics Division & Board Member
MCMarco Castagneto
Marco CastagnetoChief Scientific Officer & Director of Medical Device Division

Board

GM
Geltrude MingroneChief Advisor

Investors · 2

Related companies · 1

Companies working in the same space as Keyron Medical.

In the news

Frequently asked questions

What does Keyron Medical do?
Keyron develops ForePass, a fully endoscopic, non-invasive and reversible gastric bypass medical device intended to reproduce the effects of metabolic surgery for patients with Class II & III obesity, type 2 diabetes, MASH/NASH, and liver fibrosis. The company targets severe "diabesity" patients who refuse surgery or do not achieve results with drugs, across the US and EU5 markets.
Who founded Keyron Medical?
Keyron Medical was founded by Giorgio Castagneto Gissey in 2016.
Who are Keyron Medical's investors?
Keyron Medical's investors include Health Wildcatters, Riceberg Ventures Premier.